After attending a lab’s seminar about diagnostic tests for breast cancer survivors, one patient learns that something isn’t right with the medication she’s taking to prevent the cancer from reoccurring. Can the lab prove to her oncologist that she will do better on a higher dosage?
Alan H.B. Wu, PhD, DABCC, FAACC
Professor of Laboratory Medicine, University of California, San Francisco
Chief, Clinical Chemistry Laboratory, Zuckerberg San Francisco General Hospital & Trauma Center
San Francisco, CA
In Dr. Wu’s current role, his clinical and research laboratory conducts testing for routine analytes in blood, urine, and cerebral spinal fluid for electrolytes, metabolites, hormones, proteins, and biomarkers. His particular area of interest is in cardiac biomarkers for acute cardiac diseases.
